NEWS
SHL MEDICAL | 2017.10

Connect with SHL Group at Outsourced Pharma 2017 San Francisco

SHL Group is excited to announce our participation as an exhibitor at Outsourced Pharma 2017 in San Francisco, CA from October 17-18. SHL will show a wide range of capabilities assembling, labeling and packaging for auto injectors and pen injectors at Booth 63. We look forward to welcoming pharma’s best and brightest and helping them meet their clinical and commercial needs, from innovative device design through to world-class device assembly, labeling and packaging.

The rapid growth of the biologics and biosimilars market has created a significant demand for self-injection devices for the treatment of chronic indications. Biologics are often prescribed for chronic conditions where patients need frequent injections and are often required to self-administer medications at home. Biologic drug products have been growing significantly in market share the last few years. Currently, the number of biotechnology products under development exceeds that of conventional drug products. With the increased market share of biologic drugs and the growth in the biosimilar market, SHL is planning for the future with new, innovative drug delivery devices focused on the patient’s needs and building an infrastructure to streamline the development process.

To learn more about our injection devices, visit us at Booth 63 at the Hyatt Regency San Francisco Airport or online at www.shl-group.com.

About SHL

SHL is one of the world’s largest solution providers in design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.

With over 3,500 staff worldwide, our organization consists of several distinct group companies:

SHL Medical Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies

SHL Healthcare Develops and manufactures equipment solutions for home, hospital and long term care use

SHL Technologies Provides contract manufacturing and engineering services for the production of complex medtech and industrial products

For additional information visit www.shl-group.com or contact us at info@shl-group.com